US drug companies paid $15bn fines for criminal and civil violations over the past five years

BMJ 2010; 341 doi: http://dx.doi.org/10.1136/bmj.c7360 (Published 21 December 2010)
Cite this as: BMJ 2010;341:c7360

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Janice Hopkins Tanne
  1. 1New York

Illegal marketing activities by drug companies have risen over the past five years, leading to major penalties when companies forced to settle with the federal and state governments, says Public Citizen, an independent US watchdog organisation. It has called the drug industry “the biggest defrauder of the federal government.”

Although reports of drug companies’ misdeeds have been reported before, Public Citizen’s new report summarises the situation.

Industry spokespeople said that the problems were behind them and that the industry had put stricter guidelines in place.

Sidney Wolfe, director of Public Citizen’s health research group, told the BMJ that in the past five years the drug industry moved ahead of the defence industry and all other industry sectors in the amount of civil penalties for fraud under the False Claims Act against the federal government. The report said that of 165 drug company settlements comprising $19.8bn (£12.8bn; €15bn) in penalties over the past 20 years, 73% …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL